Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increasing prevalence of HDV/HBV infection over 15 years in France
Annabelle Servant‐Delmas, Frédéric Le Gal, Pierre Gallian, et al.
Journal of Clinical Virology (2013) Vol. 59, Iss. 2, pp. 126-128
Closed Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis
Haiyan Chen, Danting Shen, Dong‐Ze Ji, et al.
Gut (2018) Vol. 68, Iss. 3, pp. 512-521
Closed Access | Times Cited: 335
The changing context of hepatitis D
Mario Rizzetto, Saeed Hamid, F. Negro
Journal of Hepatology (2021) Vol. 74, Iss. 5, pp. 1200-1211
Open Access | Times Cited: 126
Hepatitis D Virus: Introduction and Epidemiology
Mario Rizzetto
Cold Spring Harbor Perspectives in Medicine (2015) Vol. 5, Iss. 7, pp. a021576-a021576
Open Access | Times Cited: 157
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta
Dominique Roulot, Ségolène Brichler, Richard Layese, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 5, pp. 1046-1062
Open Access | Times Cited: 115
A review on hepatitis D: From virology to new therapies
Nathalie Mentha, Sophie Clément, Francesco Negro, et al.
Journal of Advanced Research (2019) Vol. 17, pp. 3-15
Open Access | Times Cited: 104
Pathogenesis of and New Therapies for Hepatitis D
Christopher Koh, Theo Heller, Jeffrey S. Glenn
Gastroenterology (2018) Vol. 156, Iss. 2, pp. 461-476.e1
Open Access | Times Cited: 97
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
Devin Razavi‐Shearer, Hannah Child, K. Razavi-Shearer, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 232-242
Open Access | Times Cited: 32
A Review of HDV Infection
Gian Paolo Caviglia, Alessia Ciancio, Mario Rizzetto
Viruses (2022) Vol. 14, Iss. 8, pp. 1749-1749
Open Access | Times Cited: 36
Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options
Dulce Alfaiate, Paul Dény, David Durantel
Antiviral Research (2015) Vol. 122, pp. 112-129
Closed Access | Times Cited: 58
Noninvasive markers for staging fibrosis in chronic delta hepatitis
Varun Takyar, Pallavi Surana, David E. Kleiner, et al.
Alimentary Pharmacology & Therapeutics (2016) Vol. 45, Iss. 1, pp. 127-138
Open Access | Times Cited: 55
HBV/HDV Co-Infection: Epidemiological and Clinical Changes, Recent Knowledge and Future Challenges
Caterina Sagnelli, Evangelista Sagnelli, Antonio Russo, et al.
Life (2021) Vol. 11, Iss. 2, pp. 169-169
Open Access | Times Cited: 37
Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?
Aslıhan Demirel, Süleyman Uraz, Zeynep Deniz, et al.
Journal of Viral Hepatitis (2023) Vol. 31, Iss. 2, pp. 120-128
Closed Access | Times Cited: 13
Hepatitis B Virus‐Hepatitis D Virus mother‐to‐child co‐transmission: A retrospective study in a developed country
Pierre Sellier, Sarah Maylin, Ségolène Brichler, et al.
Liver International (2017) Vol. 38, Iss. 4, pp. 611-618
Closed Access | Times Cited: 45
Hepatitis D infection: from initial discovery to current investigational therapies
Ben L. Da, Theo Heller, Christopher Koh
Gastroenterology report (2019) Vol. 7, Iss. 4, pp. 231-245
Open Access | Times Cited: 42
Hepatitis D prevalence: problems with extrapolation to global population estimates
Alexander Stockdale, Benno Kreuels, Marc R Y Henrion, et al.
Gut (2018) Vol. 69, Iss. 2, pp. 396-397
Open Access | Times Cited: 39
Screening for hepatitis B, C and D in metropolitan France from 2016 to 2022: A map based on the National Health Data System with a focus on HDV screening
Céline Rigaud, Sandrine François, Paul Carrier, et al.
(2025)
Closed Access
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada
Carla Osiowy, Ken Swidinsky, Sarah Haylock‐Jacobs, et al.
JHEP Reports (2022) Vol. 4, Iss. 5, pp. 100461-100461
Open Access | Times Cited: 17
The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
Tomoyuki Hayashi, Yumie Takeshita, Yvan Hutin, et al.
Archives of Public Health (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 22
Hepatitis B virus/hepatitis D virus epidemiology: Changes over time and possible future influence of the SARS-CoV-2 pandemic
Caterina Sagnelli, Mariantonietta Pisaturo, Caterina Curatolo, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 42, pp. 7271-7284
Open Access | Times Cited: 20
Hepatitis delta virus: From infection to new therapeutic strategies
Grazia Anna Niro, Arianna Ferro, Francesca Cicerchia, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 24, pp. 3530-3542
Open Access | Times Cited: 18
Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France
Assilina Parfut, Simona Tripon, Pierre Gantner, et al.
Journal of Clinical Virology (2024) Vol. 171, pp. 105650-105650
Closed Access | Times Cited: 2
The diagnostic cascade for patients with hepatitis delta infection in France, 2018–2022: A cross‐sectional study
Ségolène Brichler, Pascale Trimoulet, Anne‐Marie Roque‐Afonso, et al.
Liver International (2024) Vol. 44, Iss. 10, pp. 2858-2865
Open Access | Times Cited: 2
Prevalence of hepatitis delta virus among chronic hepatitis B carriers in a large tertiary center in the Netherlands
Boris J. B. Beudeker, Jolanda J.C. Voermans, Corine H. GeurtsvanKessel, et al.
Journal of Clinical Virology (2021) Vol. 141, pp. 104870-104870
Open Access | Times Cited: 15
Combination of Novel Therapies for HDV
Menashe Elazar, Jeffrey S. Glenn
Viruses (2022) Vol. 14, Iss. 2, pp. 268-268
Open Access | Times Cited: 10
Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study
Stéphane Chevaliez, Françoise Roudot‐Thoraval, C. Brouard, et al.
JHEP Reports (2022) Vol. 4, Iss. 12, pp. 100593-100593
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top